AGP Executive Report
Last update: 10 hours agoCancer Research in Chicago: At ASCO 2026, new analyses tied GLP-1 drugs (like Ozempic/Wegovy) to lower risks across multiple obesity-linked cancers and better survival in some groups, including breast cancer findings from large patient records. Personalized Immunotherapy: A Chicago-presented phase 2b trial reported that an mRNA vaccine made from a patient’s removed tumor (Intismeran) added to immunotherapy may reduce melanoma recurrence risk. Public Health Watch: The FDA is investigating two fresh foodborne illness outbreaks—one involving Listeria and another Cyclospora—while also tracking additional Salmonella cases linked to moringa supplement products. Illinois Healthcare Costs: Illinois American Water filed a $142.4M rate hike request, with critics warning of potential overcharges tied to profit and financing assumptions. Safety & Prevention: Chicago pediatric experts warn button batteries are a weekly emergency, and a local “Reese’s Law” push highlights stronger packaging and safety standards. Community & Access: Illinois lawmakers approved new unpaid, job-protected leave for parents of NICU babies, aiming to reduce gaps in maternal and newborn support.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
